Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Clinical usefulness of D2-40 in non-small cell lung cancer.

Min KH, Park SJ, Lee KS, Hwang SH, Kim SR, Moon H, Han HJ, Chung MJ, Lee YC.

Lung. 2011 Feb;189(1):57-63. doi: 10.1007/s00408-010-9268-x. Epub 2010 Nov 25.

PMID:
21107593
2.

Pathology of non-small cell lung cancer. New diagnostic approaches.

Linnoila I.

Hematol Oncol Clin North Am. 1990 Dec;4(6):1027-51. Review.

PMID:
1962774
3.

[Indications and limitations of fresh frozen sections in the pulmonary apparatus].

Pütz K, Engels M, Vollbrecht C, Heukamp LC, Adam AC, Büttner R.

Pathologe. 2012 Sep;33(5):402-6. doi: 10.1007/s00292-012-1603-y. Review. German.

PMID:
22782501
4.

[Symptoms and clinical findings in lung neoplasm].

Hirano T, Kato H.

Nihon Rinsho. 2002 May;60 Suppl 5:145-50. Review. Japanese. No abstract available.

PMID:
12101644
5.

[Clinicopathological characteristics of lung cancers 2 cm or less in diameter].

Mano M.

Nihon Rinsho. 2002 May;60 Suppl 5:557-60. Review. Japanese. No abstract available.

PMID:
12101735
6.

Is immunohistochemistry always required to diagnose lung cancer?

Rossi G, Tiseo M, Cavazza A, Colby TV.

Adv Anat Pathol. 2013 Sep;20(5):327-33. doi: 10.1097/PAP.0b013e3182a28a24. Review.

PMID:
23939149
7.

The advancement of predictive diagnosis and molecular mechanism in multiple primary lung cancer.

Yuan L, Liu LX, Che GW.

Chin J Cancer. 2010 May;29(5):575-8. Review.

8.

Classification of lung cancer.

Travis WD.

Semin Roentgenol. 2011 Jul;46(3):178-86. doi: 10.1053/j.ro.2011.02.003. Review. No abstract available.

PMID:
21726702
9.

Pathological diagnostic criterion of blood and lymphatic vessel invasion in colorectal cancer: a framework for developing an objective pathological diagnostic system using the Delphi method, from the Pathology Working Group of the Japanese Society for Cancer of the Colon and Rectum.

Kojima M, Shimazaki H, Iwaya K, Kage M, Akiba J, Ohkura Y, Horiguchi S, Shomori K, Kushima R, Ajioka Y, Nomura S, Ochiai A.

J Clin Pathol. 2013 Jul;66(7):551-8. doi: 10.1136/jclinpath-2012-201076. Epub 2013 Apr 16.

10.

Protein correlates of molecular alterations in lung adenocarcinoma: Immunohistochemistry as a surrogate for molecular analysis.

Sholl LM.

Semin Diagn Pathol. 2015 Sep;32(5):325-33. doi: 10.1053/j.semdp.2015.02.019. Epub 2015 Feb 4. Review.

PMID:
25753527
11.

Mouse models of lung squamous cell carcinomas.

You MS, Rouggly LC, You M, Wang Y.

Cancer Metastasis Rev. 2013 Jun;32(1-2):77-82. doi: 10.1007/s10555-012-9406-4. Review.

PMID:
23229817
12.

Squamous-cell carcinoma of the lungs: is it really so different?

Sereno M, Esteban IR, Zambrana F, Merino M, Gómez-Raposo C, López-Gómez M, Sáenz EC.

Crit Rev Oncol Hematol. 2012 Dec;84(3):327-39. doi: 10.1016/j.critrevonc.2012.06.009. Epub 2012 Jul 19. Review.

PMID:
22819280
13.

Druggable targets of squamous cell lung cancer.

Kim CH.

Tuberc Respir Dis (Seoul). 2013 Dec;75(6):231-5. doi: 10.4046/trd.2013.75.6.231. Epub 2013 Dec 24. Review.

Supplemental Content

Support Center